SAN DIEGO--(BUSINESS WIRE)--ImThera Medical, Inc. reported results from its European study of the aura6000™ neurostimulation device for the treatment of Obstructive Sleep Apnea (OSA) at the American Thoracic Society (ATS) 2011 Conference. Safety and efficacy outcomes of the Phase I (three-month data) protocol are positive and included results of the Phase I (three-month data) protocol.
